%0 Journal Article
%T Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
%A Andreas A. Argyriou
%A Anna Vaqu¨¦
%A Carlos Plata-Salam¨¢n
%A Chiara Briani
%A Cristina Nadal
%A Cristina Santos
%A Diego Cortinovis
%A Guido Cavaletti
%A Haralabos P. Kalofonos
%A Jes¨²s Villoria
%A Jordi Bruna
%A Mariano Sust
%A Paola Alberti
%A Roser Velasco
%A Sebasti¨¢n Videla
%A Thomas Klein
%J Archive of "Neurotherapeutics".
%D 2018
%R 10.1007/s13311-017-0572-5
%X The online version of this article (10.1007/s13311-017-0572-5) contains supplementary material, which is available to authorized users
%K Neurotoxicity
%K Neuropathic pain
%K Adverse effects
%K Chemotherapy
%K Colorectal cancer
%K MR309/E-52862
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794691/